EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Induction prior to autologous haematopoietic cell transplantation in multiple myeloma

Mohamad Mohty iD, Florent Malard iD

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19753 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Mohamad Mohty und 1 weiteren Autor:innen. Beteiligte Einrichtung: Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Centre de Recherche Saint-Antoine INSERM UMRs938, Sorbonne Un…. Hauptthemen laut MEDLINE: Multiple Myeloma, Hematopoietic Stem Cell Transplantation, Transplantation, Autologous, Induction Chemotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Induction chemotherapy followed by autologous haematopoietic cell transplantation and post‐transplant therapy (including maintenance therapy with or without prior consolidation) is still considered as the standard of care for newly diagnosed young and fit multiple myeloma patients. Over the last years, superiority of quadruplet regimens for induction was established, with the addition of an anti‐CD38 monoclonal antibody to triplet regimen including a proteasome inhibitor, an IMiD (thalidomide or lenalidomide) or cyclophosphamide, and dexamethasone. Given quadruplet induction regimens are associated with deep response, including a high‐rate of sustained measurable residual disease negativity in a significant proportion of patients, they are now recommended for induction chemotherapy when available.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaHematopoietic Stem Cell TransplantationTransplantation, AutologousInduction ChemotherapyAntineoplastic Combined Chemotherapy ProtocolsHumansDexamethasoneLenalidomideCyclophosphamide

Stichwörter der Autor:innen

chemotherapymyelomatransplantation

Substanzen

DexamethasoneLenalidomideCyclophosphamide

Autor:innen und Institutionen

  • Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Centre de Recherche Saint-Antoine INSERM UMRs938, Sorbonne Université, Paris, France.

ORCID-Profile: Mohamad Mohty, Florent Malard

Zitieren

APA

Mohty, M., & Malard, F. (2024). Induction prior to autologous haematopoietic cell transplantation in multiple myeloma. British Journal of Haematology. https://doi.org/10.1111/bjh.19753

Vancouver

Mohty M, Malard F. Induction prior to autologous haematopoietic cell transplantation in multiple myeloma. British Journal of Haematology. 2024. doi:10.1111/bjh.19753

BibTeX
@article{Mohty2024,
  author = {Mohty, Mohamad and Malard, Florent},
  title = {Induction prior to autologous haematopoietic cell transplantation in multiple myeloma},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19753}
}
Kostenlos starten →